D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Leggett & Platt
LEG
$1.33B
| $29M | 0.02% |
2,130,276
-1,170,097
| -35% | -$15.9M |
|
452
Simpson Manufacturing
SSD
$7.93B
| $28.9M | 0.02% |
151,214
-61,708
| -29% | -$11.8M |
|
453
Viking Therapeutics
VKTX
$2.82B
| $28.9M | 0.02% |
456,460
-69,042
| -13% | -$4.37M |
|
454
Biohaven
BHVN
$1.48B
| $28.9M | 0.02% |
577,723
+37,297
| +7% | +$1.86M |
|
455
MongoDB
MDB
$27.2B
| $28.8M | 0.02% |
106,565
-12,807
| -11% | -$3.46M |
|
456
Jazz Pharmaceuticals
JAZZ
$7.71B
| $28.8M | 0.02% |
258,399
+2,528
| +1% | +$282K |
|
457
Expedia Group
EXPE
$26.6B
| $28.7M | 0.02% |
193,916
-268,805
| -58% | -$39.8M |
|
458
Coca-Cola Consolidated
COKE
$10.5B
| $28.6M | 0.02% |
217,620
+69,130
| +47% | +$9.1M |
|
459
Elevance Health
ELV
$69.4B
| $28.6M | 0.02% |
55,067
-185,189
| -77% | -$96.3M |
|
460
Hecla Mining
HL
$7.27B
| $28.5M | 0.02% |
4,277,153
+2,990,941
| +233% | +$19.9M |
|
461
Telus
TU
$24.2B
| $28.4M | 0.02% |
1,693,049
+1,289,969
| +320% | +$21.6M |
|
462
Genworth Financial
GNW
$3.51B
| $28.4M | 0.02% |
4,140,954
+88,333
| +2% | +$605K |
|
463
Qiagen
QGEN
$10B
| $28.2M | 0.02% |
602,617
+405,262
| +205% | +$19M |
|
464
First Industrial Realty Trust
FR
$6.79B
| $28.1M | 0.02% |
502,065
-29,835
| -6% | -$1.67M |
|
465
Celldex Therapeutics
CLDX
$1.67B
| $28M | 0.02% |
825,117
-20,443
| -2% | -$695K |
|
466
Monolithic Power Systems
MPWR
$40.8B
| $28M | 0.02% |
30,293
-10,394
| -26% | -$9.61M |
|
467
Harrow
HROW
$1.45B
| $28M | 0.02% |
+622,818
| New | +$28M |
|
468
Altice USA
ATUS
$1.08B
| $28M | 0.02% |
11,365,550
-165,145
| -1% | -$406K |
|
469
D.R. Horton
DHI
$52.6B
| $27.9M | 0.02% |
146,168
-368,237
| -72% | -$70.2M |
|
470
Unum
UNM
$12.5B
| $27.8M | 0.02% |
468,366
-220,317
| -32% | -$13.1M |
|
471
Dollar General
DG
$23.3B
| $27.8M | 0.02% |
328,350
-684,602
| -68% | -$57.9M |
|
472
QuantumScape
QS
$4.69B
| $27.7M | 0.02% |
4,818,074
+550,067
| +13% | +$3.16M |
|
473
Franco-Nevada
FNV
$38.1B
| $27.7M | 0.02% |
222,628
+83,039
| +59% | +$10.3M |
|
474
Pebblebrook Hotel Trust
PEB
$1.36B
| $27.5M | 0.02% |
2,080,252
+116,864
| +6% | +$1.55M |
|
475
NIO
NIO
$12.8B
| $27.5M | 0.02% |
4,112,613
+3,410,223
| +486% | +$22.8M |
|